Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Atsushi Oba to Pancreatic Neoplasms

This is a "connection" page, showing publications Atsushi Oba has written about Pancreatic Neoplasms.

 
Connection Strength
 
 
 
12.827
 
  1. Oba A, Shimane G, Makuuchi R, Kiritani S, Kobayashi K, Ri M, Ono Y, Hayami M, Irino T, Ito H, Inoue Y, Ohashi M, Nunobe S, Takahashi Y. Robotic Pancreatectomy as an Adjunct to Radical Gastrectomy for Advanced Gastric Cancer: Surgical and Clinical Implications. Ann Surg Oncol. 2026 Apr; 33(4):3473-3474.
    View in: PubMed
    Score: 0.514
  2. Oba A, Tanaka K, Inoue Y, Valente R, Rangelova E, Arnelo U, Ono Y, Sato T, Torphy RJ, Ito H, Löhr M, Takahashi Y, Schulick RD, Saiura A, Sparrelid E, Del Chiaro M. Pancreatectomies with vein resection: Two large institutions' experience of East and West. Pancreatology. 2025 Mar; 25(2):250-257.
    View in: PubMed
    Score: 0.484
  3. Oba A, Maekawa A, Inoue Y, Makuuchi R, Omiya K, Kobayashi K, Ono Y, Sato T, Ohashi M, Ito H, Nunobe S, Takahashi Y. Robotic Splenic Vessels Preserving Distal Pancreatectomy in a Post-Distal Gastrectomy Patient. Ann Surg Oncol. 2023 Oct; 30(11):6680-6681.
    View in: PubMed
    Score: 0.437
  4. Oba A, Maekawa A, Makuuchi R, Inoue Y, Takahashi Y. ASO Author Reflections: Open/Robotic-Splenic Vessels Preserving Distal Pancreatectomy can be a Good Option for Post-Distal Gastrectomy Patients. Ann Surg Oncol. 2023 10; 30(11):6682-6683.
    View in: PubMed
    Score: 0.435
  5. Oba A, Del Chiaro M, Fujii T, Okano K, Stoop TF, Wu YHA, Maekawa A, Yoshida Y, Hashimoto D, Sugawara T, Inoue Y, Tanabe M, Sho M, Sasaki T, Takahashi Y, Matsumoto I, Sasahira N, Nagakawa Y, Satoi S, Schulick RD, Yoon YS, He J, Jang JY, Wolfgang CL, Hackert T, Besselink MG, Takaori K, Takeyama Y. "Conversion surgery" for locally advanced pancreatic cancer: A position paper by the study group at the joint meeting of the International Association of Pancreatology (IAP) & Japan Pancreas Society (JPS) 2022. Pancreatology. 2023 Sep; 23(6):712-720.
    View in: PubMed
    Score: 0.433
  6. Oba A, Wu YHA, Schulick R, Del Chiaro M. Author response to: Comment on: Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis. Br J Surg. 2022 12 13; 110(1):112.
    View in: PubMed
    Score: 0.419
  7. Oba A, Wu YHA, Colborn KL, Karam SD, Meguid C, Al-Musawi MH, Bao QR, Gleisner AL, Ahrendt S, Schulick RD, Del Chiaro M. Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis. Br J Surg. 2022 04 19; 109(5):450-454.
    View in: PubMed
    Score: 0.400
  8. Oba A, Croce C, Hosokawa P, Meguid C, Torphy RJ, Al-Musawi MH, Ahrendt S, Gleisner A, Schulick RD, Del Chiaro M. Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines. Ann Surg. 2022 01 01; 275(1):175-181.
    View in: PubMed
    Score: 0.392
  9. Oba A, Del Chiaro M, Satoi S, Kim SW, Takahashi H, Yu J, Hioki M, Tanaka M, Kato Y, Ariake K, Wu YHA, Inoue Y, Takahashi Y, Hackert T, Wolfgang CL, Besselink MG, Schulick RD, Nagakawa Y, Isaji S, Tsuchida A, Endo I. New criteria of resectability for pancreatic cancer: A position paper by the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS). J Hepatobiliary Pancreat Sci. 2022 Jul; 29(7):725-731.
    View in: PubMed
    Score: 0.387
  10. Oba A, Wu YHA, Lieu CH, Meguid C, Colborn KL, Beaty L, Al-Musawi MH, Davis SL, Leal AD, Purcell T, King G, Wooten ES, Fujiwara Y, Goodman KA, Schefter T, Karam SD, Gleisner AL, Ahrendt S, Leong S, Messersmith WA, Schulick RD, Del Chiaro M. Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study. Br J Surg. 2021 08 19; 108(8):976-982.
    View in: PubMed
    Score: 0.382
  11. Oba A, Stoop TF, Löhr M, Hackert T, Zyromski N, Nealon WH, Unno M, Schulick RD, Al-Musawi MH, Wu W, Zhao Y, Satoi S, Wolfgang CL, Abu Hilal M, Besselink MG, Del Chiaro M. Global Survey on Pancreatic Surgery During the COVID-19 Pandemic. Ann Surg. 2020 08; 272(2):e87-e93.
    View in: PubMed
    Score: 0.355
  12. Wu YHA, Samuels JM, Harnke B, Negrini D, Al-Musawi MH, Meguid C, Ahrendt S, Schulick RD, Del Chiaro M, Oba A. Multifocal/diffuse pancreatic serous cystic neoplasms: Systematic review with a new case. Pancreatology. 2020 Jul; 20(5):902-909.
    View in: PubMed
    Score: 0.349
  13. Oba A, Bao QR, Barnett CC, Al-Musawi MH, Croce C, Schulick RD, Del Chiaro M. Vascular Resections for Pancreatic Ductal Adenocarcinoma: Vascular Resections for PDAC. Scand J Surg. 2020 Mar; 109(1):18-28.
    View in: PubMed
    Score: 0.342
  14. Oba A, Inoue Y, Ono Y, Irie S, Sato T, Mise Y, Ito H, Takahashi Y, Saiura A. Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection? Langenbecks Arch Surg. 2020 Feb; 405(1):35-41.
    View in: PubMed
    Score: 0.339
  15. Oba A, Kudo A, Akahoshi K, Kishino M, Akashi T, Katsuta E, Iwao Y, Ono H, Mitsunori Y, Ban D, Tanaka S, Eishi Y, Tateishi U, Tanabe M. A simple morphological classification to estimate the malignant potential of pancreatic neuroendocrine tumors. J Gastroenterol. 2017 10; 52(10):1140-1146.
    View in: PubMed
    Score: 0.284
  16. Oba A, Ban D, Kirimura S, Akahoshi K, Mitsunori Y, Matsumura S, Ochiai T, Kudo A, Tanaka S, Minoru T. Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. 2016 Aug; 23(8):480-8.
    View in: PubMed
    Score: 0.267
  17. Stoop TF, Croce C, Ishida H, Ali M, Javed AA, Halimi A, Oba A, Groot Koerkamp B, Leonhardt CS, Thiels CA, Rangelova E, Sparrelid E, Sotirova I, Leiting JL, Tauchi J, Kobayashi K, Klos M, Beuk LPM, Genova L, Mastronardi M, Kendrick ML, Mughal NA, Busch OR, Franklin O, Larsson P, Klaiber U, Schulick RD, Theijse RT, Strobel O, Ghorbani P, de Wilde RF, Rodriguez Franco S, Sugawara T, Wilmink JW, Messersmith W, Besselink MG, Wolfgang CL, Inoue Y, Truty MJ, Del Chiaro M. Neurogenic diarrhoea after superior mesenteric artery divestment or resection for pancreatic adenocarcinoma following preoperative chemotherapy: international multicentre retrospective study. BJS Open. 2026 May 12; 10(3).
    View in: PubMed
    Score: 0.133
  18. Tsybulskyi D, Hashimoto D, Tanaka K, Murotani K, Taguri M, Yamaki S, Sato S, Oba A, Inoue Y, Otsuka S, Ohgi K, Sugiura T, Shintakuya R, Okada K, Uemura K, Inoue K, Mizuma M, Unno M, Asano T, Nakagawa N, Takami H, Takahashi R, Motoi F, Akahoshi K, Ban D, Gulla A, Ishikawa H, Hirano S, Satoi S. Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression Model. J Hepatobiliary Pancreat Sci. 2026 Mar; 33(3):216-227.
    View in: PubMed
    Score: 0.129
  19. Ito R, Oba A, Baba H, Shimane G, Sugiura K, Sawa Y, Shibata Y, Kiritani S, Kobayashi K, Ono Y, Inoue Y, Ito H, Yoshioka R, Mise Y, Saiura A, Takahashi Y. A Widely Applicable CAD-Based Intraoperative 3D Navigation Method for Hepatopancreatobiliary Surgery. Ann Surg Oncol. 2026 Apr; 33(4):3421-3422.
    View in: PubMed
    Score: 0.129
  20. Miyata T, Oba A, Kato T, Maekawa A, Tsuchiya S, Baba H, Tauchi J, Kobayashi K, Ono Y, Sasaki T, Ozaka M, Sasahira N, Ito H, Iwatsuki M, Matsueda K, Inoue Y, Takahashi Y. Surgical Challenges Associated with Collateral Veins Formation in Pancreatic Cancer with Vein Resection. Ann Surg Oncol. 2026 Apr; 33(4):3535-3544.
    View in: PubMed
    Score: 0.129
  21. Stoop TF, Lutchman KRD, Theijse RT, Larsson P, Oba A, Groot Koerkamp B, van Eijck CHJ, Wolfgang CL, Rangelova E, Marchegiani G, Endo I, Jang JY, Primrose JM, Ramia JM, Katz MHG, Abu Hilal M, Ghorbani P, Shrikhande SV, Hackert T, Nealon WH, Truty MJ, Del Chiaro M, Besselink MG. Staging laparoscopy to detect occult metastases in localized pancreatic cancer: global survey among nine international societies. HPB (Oxford). 2026 Mar; 28(3):313-323.
    View in: PubMed
    Score: 0.129
  22. Maekawa A, Oba A, Mie T, Sawa Y, Baba H, Kobayashi K, Ono Y, Sato T, Ito H, Sasaki T, Ozaka M, Sasahira N, Takamatsu M, Ban D, Inoue Y, Takahashi Y. Exploring the role of CA 19-9 dynamics in pancreatic cancer multidisciplinary treatment: Proposal of the PANC classification. Surgery. 2025 Dec; 188:109783.
    View in: PubMed
    Score: 0.127
  23. Shimane G, Ono Y, Inoue Y, Ito H, Oba A, Kobayashi K, Takahashi Y. Anatomical evaluation of the perinephric vein as a surgical landmark in minimally invasive distal pancreatectomy for pancreatic cancer. Surg Endosc. 2025 Oct; 39(10):7014-7022.
    View in: PubMed
    Score: 0.126
  24. Kato T, Ono Y, Kitazawa T, Kobayashi K, Oba A, Sato T, Ito H, Inoue Y, Saiura A, Takahashi Y. Impact of Preoperative Diabetes on Insulin Management and Nutritional Status After Total or Completion Pancreatectomy. Ann Surg Oncol. 2025 Oct; 32(10):7422-7432.
    View in: PubMed
    Score: 0.125
  25. Omiya K, Oba A, Sugiura K, Maekawa A, Mie T, Kobayashi K, Ono Y, Sasaki T, Ozaka M, Sasahira N, Ito H, Inoue Y, Takahashi Y. Resectable Pancreatic Cancer with CA19-9 > 500 U/mL: A Biological Indicator for Survival Benefit with Intensive Neoadjuvant Chemotherapy. Ann Surg Oncol. 2025 Aug; 32(8):5411-5420.
    View in: PubMed
    Score: 0.124
  26. Stoop TF, Wu YHA, Oba A, Ali M, Feld IM, Al-Musawi MH, Jain A, Saiura A, Sauvanet A, Coppola A, Javed AA, Groot Koerkamp B, Miller BN, Hashimoto D, Caputo D, Kleive D, Sereni E, Kazemier G, Belfiori G, Ishida H, van Dam JL, Dembinski J, Akahoshi K, Roberts KJ, Tanaka K, Labori KJ, Falconi M, House MG, Sugimoto M, Tanabe M, Gotohda N, Chatzizacharias N, Krohn PS, Dokmak S, Rodriguez Franco S, Hirano S, Burgdorf SK, Crippa S, Satoi S, Nguyen TK, Yamamoto T, Nakamura T, Ushida Y, Bachu V, Burns WR, Inoue Y, Takahashi Y, Aslami Z, Schulick RD, He J, Messersmith W, Besselink MG, Burkhart RA, Wilmink JW, Del Chiaro M. Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study. Br J Cancer. 2025 Jul; 133(1):76-84.
    View in: PubMed
    Score: 0.124
  27. Stoop TF, Javed AA, Oba A, Koerkamp BG, Seufferlein T, Wilmink JW, Besselink MG. Pancreatic cancer. Lancet. 2025 04 05; 405(10485):1182-1202.
    View in: PubMed
    Score: 0.123
  28. Baba H, Oba A, Maekawa A, Kiritani S, Kobayashi H, Takahashi A, Omiya K, Kobayashi K, Ono Y, Sato T, Ito H, Inoue Y, Takahashi Y. Polyglycolic Acid Mesh and Fibrin Glue in Minimally Invasive Left Pancreatectomy: Video Technique and Single-Center Data. Ann Surg Oncol. 2025 Jul; 32(7):5102-5103.
    View in: PubMed
    Score: 0.123
  29. Ono Y, Ito R, Kobayashi K, Oba A, Sato T, Ito H, Inoue Y, Takahashi Y. Technique of Circumferential Divestment of the Superior Mesenteric Artery for Locally Advanced Pancreatic Cancer. Ann Surg Oncol. 2025 Jun; 32(6):4417-4418.
    View in: PubMed
    Score: 0.122
  30. Ishida H, Stoop TF, Oba A, Bachellier P, Ban D, Endo I, Franklin O, Fujii T, Gulla A, Hackert T, Halimi A, Hirano S, Jang JY, Katz MHG, Maekawa A, Nealon WH, Perri G, Ramia JM, Rompen IF, Satoi S, Schulick RD, Shrikhande SV, Tsung A, Wolfgang CL, Besselink MG, Del Chiaro M. Global survey on surgeon preference and current practice for pancreatic neck and body cancer with portomesenteric venous involvement. HPB (Oxford). 2025 Jul; 27(7):910-921.
    View in: PubMed
    Score: 0.122
  31. Hirose Y, Oba A, Inoue Y, Maekawa A, Kobayashi K, Omiya K, Takahashi A, Ono Y, Sato T, Ito H, Mie T, Sasaki T, Ozaka M, Sasahira N, Wakai T, Takahashi Y. Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal comparative study. BJS Open. 2025 Mar 04; 9(2).
    View in: PubMed
    Score: 0.122
  32. Stoop TF, Sugawara T, Oba A, Feld IM, van Roessel S, van Veldhuisen E, Wu YHA, Nishino J, Ali M, Alseidi A, Sauvanet A, Mirabella A, Sa Cunha A, Kokkola A, Groot Koerkamp B, Pietrasz D, Kleive D, Butturini G, Malleo G, van Laarhoven HWM, Frigerio I, Dembinski J, He J, Gagnière J, Kleeff J, Ramia JM, Roberts KJ, Labori KJ, Marino MV, Falconi M, B Mortensen M, Lesurtel M, Bonds M, Chatzizacharias N, Strobel O, Turrini O, Griffin O, Franklin O, Pfeiffer P, Schulick RD, Salvia R, de Wilde RF, Dokmak S, Rodriguez Franco S, Augustinus S, Burgdorf SK, Crippa S, Hackert T, Tarvainen T, Burns WR, Messersmith W, Wilmink JW, Burkhart RA, Del Chiaro M, Besselink MG. Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX. JAMA Oncol. 2025 Mar 01; 11(3):276-287.
    View in: PubMed
    Score: 0.122
  33. Kiritani S, Inoue Y, Sato T, Sawa Y, Kobayashi K, Oba A, Ono Y, Ito H, Takahashi Y. A left-posterior approach to the superior mesenteric artery during robot-assisted pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci. 2025 Apr; 32(4):317-326.
    View in: PubMed
    Score: 0.122
  34. Maekawa A, Omiya K, Oba A, Inoue Y, Hirose Y, Kobayashi K, Ono Y, Sato T, Sasaki T, Ozaka M, Matsueda K, Mise Y, Takamatsu M, Shigematsu Y, Ito H, Saiura A, Sasahira N, Takahashi Y. Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. Eur J Surg Oncol. 2025 05; 51(5):109635.
    View in: PubMed
    Score: 0.121
  35. Irie S, Inoue Y, Oba A, Ono Y, Sato T, Mise Y, Ito H, Saiura A, Takahashi Y. Technical Guidelines for Safe Mesojejunum Dissection During Pancreaticoduodenectomy: Unveiling Critical Techniques in a Complex Procedure. Ann Surg Oncol. 2025 Mar; 32(3):1850-1857.
    View in: PubMed
    Score: 0.120
  36. Hirose Y, Oba A, Takamatsu M, Hamada T, Takeda T, Suzuki T, Maekawa A, Kitano Y, Sato S, Kobayashi K, Omiya K, Ono Y, Sato T, Ito H, Sasaki T, Ozaka M, Takeuchi K, Sasahira N, Inoue Y, Wakai T, Takahashi Y. Caveolin-1 expression is a predictor of survival and recurrence patterns in resected pancreatic ductal adenocarcinoma. Pancreatology. 2024 Nov; 24(7):1021-1030.
    View in: PubMed
    Score: 0.119
  37. Omiya K, Inoue Y, Kobayashi K, Oba A, Ono Y, Sato T, Ito H, Takahashi Y. ASO Author Reflections: Advanced Techniques in Robot-Assisted Pancreaticoduodenectomy with Dissection of the Nerve Plexus Around the Superior Mesenteric Artery for Invasive Pancreatic Head Cancer. Ann Surg Oncol. 2024 Oct; 31(10):7076-7077.
    View in: PubMed
    Score: 0.117
  38. Omiya K, Inoue Y, Kobayashi K, Oba A, Ono Y, Sato T, Ito H, Takahashi Y. Robot-Assisted Pancreaticoduodenectomy with Hemicircumferential Dissection of Nerve Plexus Around the Superior Mesenteric Artery. Ann Surg Oncol. 2024 Oct; 31(10):7064-7065.
    View in: PubMed
    Score: 0.117
  39. Sato S, Inoue Y, Oba A, Ono Y, Sato T, Ito H, Takahashi Y. Scope transition and early arterial inflow control provide safe and comfortable dissection in robotic distal pancreatectomy. Langenbecks Arch Surg. 2024 Jun 03; 409(1):171.
    View in: PubMed
    Score: 0.116
  40. Stoop TF, Oba A, Wu YHA, Beaty LE, Colborn KL, Janssen BV, Al-Musawi MH, Franco SR, Sugawara T, Franklin O, Jain A, Saiura A, Sauvanet A, Coppola A, Javed AA, Groot Koerkamp B, Miller BN, Mack CE, Hashimoto D, Caputo D, Kleive D, Sereni E, Belfiori G, Ichida H, van Dam JL, Dembinski J, Akahoshi K, Roberts KJ, Tanaka K, Labori KJ, Falconi M, House MG, Sugimoto M, Tanabe M, Gotohda N, Krohn PS, Burkhart RA, Thakkar RG, Pande R, Dokmak S, Hirano S, Burgdorf SK, Crippa S, van Roessel S, Satoi S, White SA, Hackert T, Nguyen TK, Yamamoto T, Nakamura T, Bachu V, Burns WR, Inoue Y, Takahashi Y, Ushida Y, Aslami ZV, Verbeke CS, Fariña A, He J, Wilmink JW, Messersmith W, Verheij J, Kaplan J, Schulick RD, Besselink MG, Del Chiaro M. Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy. JAMA Netw Open. 2024 06 03; 7(6):e2417625.
    View in: PubMed
    Score: 0.116
  41. Kiritani S, Ono Y, Takamatsu M, Yoshio S, Miyashita M, Oba A, Sato T, Ito H, Inoue Y, Saiura A, Takahashi Y. ASO Visual Abstract: Unique Biology of Pancreatic Ductal Adenocarcinoma Accompanied by Rapidly Impaired Diabetes: A Favorable Long-term Survival after Curative Resection. Ann Surg Oncol. 2024 Mar; 31(3):1944-1945.
    View in: PubMed
    Score: 0.114
  42. Maekawa A, Oba A, Inoue Y, Omiya K, Ono Y, Sato T, Watanabe S, Uchino Y, Kobayashi K, Ito H, Sato Y, Tanabe M, Saiura A, Takahashi Y. ASO Visual Abstract: Technical Strategy for Pancreatic Body Cancers-A Raison d'Etre of Distal Pancreatectomy With Portal Resection. Ann Surg Oncol. 2024 Feb; 31(2):1371-1372.
    View in: PubMed
    Score: 0.113
  43. Omiya K, Maekawa A, Oba A, Inoue Y, Hirose Y, Kobayashi K, Ono Y, Sato T, Ichinose J, Sasaki T, Ozaka M, Wu YHA, Hiratsuka M, Matsueda K, Mun M, Sasahira N, Ito H, Saiura A, Takahashi Y. A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of multidisciplinary treatment. Br J Surg. 2024 01 03; 111(1).
    View in: PubMed
    Score: 0.113
  44. Takeda T, Sasaki T, Ichinose J, Inoue Y, Okamoto T, Mie T, Furukawa T, Kasuga A, Oba A, Matsuura Y, Nakao M, Ozaka M, Mun M, Takahashi Y, Sasahira N. Outcomes of lung oligometastasis in pancreatic cancer. Jpn J Clin Oncol. 2023 Dec 07; 53(12):1144-1152.
    View in: PubMed
    Score: 0.112
  45. Maekawa A, Oba A, Omiya K, Inoue Y, Takahashi Y. ASO Author Reflections: Surgical Strategies for Pancreatic Body Cancers with Portal Vein Involvement: Distal Pancreatectomy or Pancreaticoduodenectomy? Ann Surg Oncol. 2024 02; 31(2):1366-1367.
    View in: PubMed
    Score: 0.112
  46. Maekawa A, Oba A, Inoue Y, Omiya K, Ono Y, Sato T, Watanabe S, Uchino Y, Kobayashi K, Ito H, Sato Y, Tanabe M, Saiura A, Takahashi Y. Technical Strategy for Pancreatic Body Cancers: A Raison d'etre of Distal Pancreatectomy with Portal Resection. Ann Surg Oncol. 2024 Feb; 31(2):1347-1357.
    View in: PubMed
    Score: 0.111
  47. Kiritani S, Ono Y, Takamatsu M, Yoshio S, Miyashita M, Oba A, Sato T, Ito H, Inoue Y, Saiura A, Takahashi Y. Unique Biology of Pancreatic Ductal Adenocarcinoma Accompanied by Rapidly Impaired Diabetes: A Favorable Long-Term Survival Following Curative Resection. Ann Surg Oncol. 2024 Jan; 31(1):514-524.
    View in: PubMed
    Score: 0.111
  48. Sato T, Inoue Y, Oba A, Ono Y, Ito H, Takahashi Y. Laparoscopic dissection around the superior mesenteric artery by left posterior approach during pancreaticoduodenectomy. Surg Endosc. 2023 11; 37(11):8871-8878.
    View in: PubMed
    Score: 0.110
  49. Nakamura T, Okada KI, Ohtsuka M, Higuchi R, Takahashi H, Nagai K, Unno M, Murakami Y, Oba A, Tomikawa M, Kato A, Horiguchi A, Nakamura M, Yagi S, Satoi S, Endo I, Amano R, Matsumoto I, Ito YM, Nagakawa T, Hirano S. Insights from managing clinical issues in distal pancreatectomy with en bloc coeliac axis resection: experiences from 626 patients. Br J Surg. 2023 09 06; 110(10):1387-1394.
    View in: PubMed
    Score: 0.110
  50. Takagi K, Inoue Y, Oba A, Ono Y, Sato T, Ito H, Saino Y, Saiura A, Takahashi Y. Impact of sarcopenia on S1 adjuvant chemotherapy and prognosis in pancreatic cancer patients. Biosci Trends. 2023 Sep 15; 17(4):310-317.
    View in: PubMed
    Score: 0.110
  51. Hashimoto D, Satoi S, Fujii T, Sho M, He J, Hackert T, Del Chiaro M, Jang JY, Gulla A, Yoon YS, Shan YS, Lou W, Valente R, Furuse J, Oba A, Nagai M, Terai T, Tanaka H, Sakai A, Yamamoto T, Yamaki S, Matsumoto I, Murakami Y, Takaori K, Takeyama Y. Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A position paper by experts in pancreatic surgery at the Joint Meeting of the International Association of Pancreatology (IAP) & the Japan Pancreas Society (JPS) 2022 in Kyoto. Pancreatology. 2023 Sep; 23(6):682-688.
    View in: PubMed
    Score: 0.109
  52. Kiritani S, Oba A, Inoue Y, Ono Y, Sato T, Ito H, Takahashi Y. ASO Author Reflections: The Jejunum Patch Technique is Effective and Easy to Use During Central Pancreatectomy. Ann Surg Oncol. 2023 09; 30(9):5763-5764.
    View in: PubMed
    Score: 0.109
  53. Kiritani S, Oba A, Inoue Y, Ono Y, Sato T, Ito H, Takahashi Y. Jejunum Patch Technique During Robot-Assisted Central Pancreatectomy: A Lesson from Open Procedure Experience. Ann Surg Oncol. 2023 Sep; 30(9):5761-5762.
    View in: PubMed
    Score: 0.108
  54. Masugi Y, Takamatsu M, Tanaka M, Hara K, Inoue Y, Hamada T, Suzuki T, Arita J, Hirose Y, Kawaguchi Y, Nakai Y, Oba A, Sasahira N, Shimane G, Takeda T, Tateishi K, Uemura S, Fujishiro M, Hasegawa K, Kitago M, Takahashi Y, Ushiku T, Takeuchi K, Sakamoto M. Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression. J Pathol Clin Res. 2023 09; 9(5):339-353.
    View in: PubMed
    Score: 0.108
  55. Kazami Y, Oba A, Ono Y, Sato T, Inoue Y, Saiura A, Takahashi Y, Ito H. Intraoperative paraaortic lymph node sampling during resection for pancreatic cancer: evolving role in the modern chemotherapy era. HPB (Oxford). 2023 10; 25(10):1169-1178.
    View in: PubMed
    Score: 0.108
  56. Sato S, Oba A, Kato T, Kobayashi K, Wu YHA, Ono Y, Sato T, Ito H, Inoue Y, Takahashi Y. Feasibility of laparoscopic radical antegrade modular pancreatosplenectomy (RAMPS) as a standard treatment for distal resectable pancreatic cancer. Langenbecks Arch Surg. 2023 May 30; 408(1):217.
    View in: PubMed
    Score: 0.108
  57. Kitano Y, Inoue Y, Takeda T, Oba A, Ono Y, Sato T, Ito H, Ozaka M, Sasaki T, Sasahira N, Baba H, Takahashi Y. Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma Compared with Upfront Surgery. Ann Surg Oncol. 2023 Aug; 30(8):5093-5102.
    View in: PubMed
    Score: 0.107
  58. Kobayashi K, Ono Y, Sato S, Kato T, Oba A, Sato T, Ito H, Inoue Y, Takamatsu M, Saiura A, Takahashi Y. Evaluation of local recurrence after pancreaticoduodenectomy for borderline resectable pancreatic head cancer with neoadjuvant chemotherapy: Can the resection level change after chemotherapy? Surgery. 2023 05; 173(5):1220-1228.
    View in: PubMed
    Score: 0.104
  59. Ono Y, Inoue Y, Ito H, Sasaki T, Takeda T, Ozaka M, Sasahira N, Hiratsuka M, Matsueda K, Oba A, Sato T, Saiura A, Takahashi Y. Analysis of prognostic factors for borderline resectable pancreatic cancer after neoadjuvant chemotherapy: the importance of CA19-9 decrease in patients with elevated pre-chemotherapy CA19-9 levels. HPB (Oxford). 2023 01; 25(1):100-108.
    View in: PubMed
    Score: 0.103
  60. Furukawa T, Takamatsu M, Inoue Y, Okamoto T, Mie T, Yamada Y, Takeda T, Kasuga A, Matsuyama M, Sasaki T, Ozaka M, Oba A, Ito H, Ono Y, Sato T, Takahashi YU, Saiura A, Sasahira N. Impact of Histological Features on Adjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Carcinoma. Anticancer Res. 2022 May; 42(5):2645-2655.
    View in: PubMed
    Score: 0.100
  61. Ushida Y, Inoue Y, Oba A, Mie T, Ito H, Ono Y, Sato T, Ozaka M, Sasaki T, Saiura A, Sasahira N, Takahashi Y. ASO Author Reflections: What are the Indications for Conversion Surgery for Initially Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel? Is Surgery Really Worthwhile after Sufficient Chemotherapy? Ann Surg Oncol. 2022 08; 29(8):5051-5052.
    View in: PubMed
    Score: 0.100
  62. Ushida Y, Inoue Y, Oba A, Mie T, Ito H, Ono Y, Sato T, Ozaka M, Sasaki T, Saiura A, Sasahira N, Takahashi Y. Optimizing Indications for Conversion Surgery Based on Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective Study. Ann Surg Oncol. 2022 Aug; 29(8):5038-5050.
    View in: PubMed
    Score: 0.099
  63. Kato T, Inoue Y, Oba A, Ono Y, Sato T, Ito H, Takahashi Y. Laparoscopic Radical Antegrade Modular Pancreatosplenectomy with Anterocranial Splenic Artery-First Approach for Left-Sided Resectable Pancreatic Cancer (with Videos). Ann Surg Oncol. 2022 Jun; 29(6):3505-3514.
    View in: PubMed
    Score: 0.099
  64. Kuroki N, Ono Y, Sato T, Inoue Y, Oba A, Ito H, Mise Y, Saiura A, Takahashi Y. Long-Term Outcome of Patients with Postoperative Refractory Diarrhea After Tailored Nerve Plexus Dissection Around the Major Visceral Arteries During Pancreatoduodenectomy for Pancreatic Cancer. World J Surg. 2022 05; 46(5):1172-1182.
    View in: PubMed
    Score: 0.099
  65. Omiya K, Oba A, Inoue Y, Kobayashi K, Wu YHA, Ono Y, Sato T, Sasaki T, Ozaka M, Sasahira N, Ito H, Saiura A, Takahashi Y. Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Nonsecretors with Pancreatic Cancer. Ann Surg. 2023 06 01; 277(6):e1278-e1283.
    View in: PubMed
    Score: 0.098
  66. Schulick RD, Oba A, Del Chiaro M. Response to the Comment on "Prognosis-based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines". Ann Surg. 2021 12 01; 274(6):e770-e771.
    View in: PubMed
    Score: 0.097
  67. Machairas N, Raptis DA, Velázquez PS, Sauvanet A, Rueda de Leon A, Oba A, Koerkamp BG, Lovasik B, Chan C, Yeo CJ, Bassi C, Ferrone CR, Kooby D, Moskal D, Tamburrino D, Yoon DS, Barroso E, de Santibañes E, Kauffmann EF, Vigia E, Robin F, Casciani F, Burdío F, Belfiori G, Malleo G, Lavu H, Hartog H, Hwang HK, Han HS, Marques HP, Poves I, Domínguez-Rosado I, Park JS, Lillemoe KD, Roberts K, Sulpice L, Besselink MG, Abuawwad M, Del Chiaro M, de Santibañes M, Falconi M, D'Silva M, Silva M, Hilal MA, Qadan M, Sell NM, Beghdadi N, Napoli N, Busch ORC, Mazza O, Muiesan P, Müller PC, Ravikumar R, Schulick R, Powell-Brett S, Abbas SH, Mackay TM, Stoop TF, Gallagher TK, Boggi U, van Eijck C, Clavien PA, Conlon KCP, Fusai GK. The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis. Ann Surg. 2021 11 01; 274(5):721-728.
    View in: PubMed
    Score: 0.097
  68. Watanabe G, Ushida Y, Oba A, Ono Y, Sato T, Inoue Y, Takahashi Y, Saiura A, Ito H. Impact of Tumor Size on the Outcomes of Patients with Resectable Distal Pancreatic Cancer: Lessons Learned from a Series of 158 Radical Resections. Ann Surg Oncol. 2022 Jan; 29(1):378-388.
    View in: PubMed
    Score: 0.095
  69. Inoue Y, Saiura A, Sato T, Oba A, Ono Y, Mise Y, Ito H, Takahashi Y. Details and Outcomes of Distal Pancreatectomy with Celiac Axis Resection Preserving the Left Gastric Arterial Flow. Ann Surg Oncol. 2021 Dec; 28(13):8283-8294.
    View in: PubMed
    Score: 0.094
  70. Inoue Y, Saiura A, Sato T, Oba A, Ono Y, Mise Y, Ito H, Takahashi Y. ASO Author Reflections: The Operative and Perioperative Strategy for Distal Pancreatectomy with Celiac Axis Resection-Can We Improve the Safety for This Morbid Operation? Ann Surg Oncol. 2021 12; 28(13):8295-8296.
    View in: PubMed
    Score: 0.094
  71. Ushida Y, Inoue Y, Ito H, Oba A, Mise Y, Ono Y, Sato T, Saiura A, Takahashi Y. High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment. Pancreatology. 2021 Jan; 21(1):130-137.
    View in: PubMed
    Score: 0.091
  72. Inoue Y, Saiura A, Oba A, Ono Y, Mise Y, Ito H, Sasaki T, Ozaka M, Sasahira N, Takahashi Y. Neoadjuvant gemcitabine and nab-paclitaxel for borderline resectable pancreatic cancers: Intention-to-treat analysis compared with upfront surgery. J Hepatobiliary Pancreat Sci. 2021 Feb; 28(2):143-155.
    View in: PubMed
    Score: 0.091
  73. Croce C, Mungo B, Oba A, Schulick RD, Del Chiaro M. ASO Author Reflections: Which Patients with Invasive Intraductal Papillary Mucinous Neoplasm Can Benefit from Adjuvant Therapy? Ann Surg Oncol. 2020 Dec; 27(Suppl 3):873-874.
    View in: PubMed
    Score: 0.089
  74. Mungo B, Croce C, Oba A, Ahrendt S, Gleisner A, Friedman C, Schulick RD, Del Chiaro M. Controversial Role of Adjuvant Therapy in Node-Negative Invasive Intraductal Papillary Mucinous Neoplasm. Ann Surg Oncol. 2021 Mar; 28(3):1533-1542.
    View in: PubMed
    Score: 0.089
  75. Inoue Y, Saiura A, Oba A, Kawakatsu S, Ono Y, Sato T, Mise Y, Ishizawa T, Takahashi Y, Ito H. Optimal Extent of Superior Mesenteric Artery Dissection during Pancreaticoduodenectomy for Pancreatic Cancer: Balancing Surgical and Oncological Safety. J Gastrointest Surg. 2019 07; 23(7):1373-1383.
    View in: PubMed
    Score: 0.078
  76. Baba H, Oba A, Tanaka K, Miura T, Ban D, Edanami M, Ishikawa Y, Ohgi K, Tanaka H, Shintakuya R, Ikenaga N, Ijichi T, Kiya Y, Muranushi R, Yamaki S, Miyazaki N, Takeuchi S, Aoki S, Mizui T, Tanaka M, Ueda H, Dei H, Takami H, Okada K, Nakata K, Mataki Y, Osakabe H, Shibuya K, Hashimoto D, Inoue Y, Hirano S, Unno M, Esaki M, Kitago M, Akahoshi K, Sugiura T, Ebata T, Uemura K, Nakamura M, Otsuka T, Nagakawa Y, Fujii T, Satoi S, Takahashi Y. The efficacy of wrapping with polyglycolic acid mesh and fibrin glue in preventing clinically relevant pancreatic fistula after minimally invasive distal pancreatectomy (WRAP Study): study protocol for a multicenter randomized controlled trial in Japan. BMC Surg. 2024 Oct 16; 24(1):314.
    View in: PubMed
    Score: 0.030
  77. Kitano Y, Inoue Y, Kobayashi H, Kobayashi K, Oba A, Ono Y, Sato T, Ito H, Takahashi Y. Development of the multiple scope transition method in robotic pancreaticoduodenectomy. Surg Endosc. 2024 10; 38(10):6169-6176.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)